Hot or Not, Stock Market Edition: 11/12/2026

Happy Thursday. Here’s what the Zen Ratings are prescribing and passing on today:

• Hot: Pharma heavyweight Merck (MRK) just raised its outlook as Keytruda, Gardasil, and several pipeline drugs add new growth catalysts; oil producer APA Corp (APA) just beat estimates while trading at roughly 7 times earnings.
• Not: Sphere Entertainment (SPHR) is down sharply as demand for its headline Wizard of Oz show cools and losses continue; WaterBridge (WBI) trades at around 130 times earnings while its projected cash burn exceeds the cash on hand.

P.S. For more stocks making moves, check out our Zen Ratings Upgrades & Downgrades screener.

A note from our sponsors...

Hoping to Retire Soon?

There's a 73-minute "trading window" that is commonly exploited by retirees and those hoping to retire sooner. It works best if you can make this trade at a very specific time of day. 

Click here to know when you should make this morning trade.

🔥 HOT: Oil and gas producer APA Corp (APA) just delivered a knockout quarter that is worth paying attention to. Earnings and revenue beat estimates, U.S. output improved, and management highlighted stronger cash flow and its plans for 2027. For investors, the setup is especially interesting because the business is improving while the stock still trades at a low earnings multiple.

And yes, our quant ratings system has already picked up on the story. APA has a Zen Rating of A, a Strong Buy recommendation … putting it in a class of stocks that have historically trounced the market. The underlying Component Grades show what is driving the call: Financials earns an A, while Value, Momentum, Sentiment, and Artificial Intelligence all receive B grades. That says the balance sheet and cash generation are strong, the valuation is attractive, and the market is increasingly rewarding the story. Bottom line: APA combines improving operations with a cheap valuation and some of the strongest financial quality on the board.

🥶 NOT: Permian water infrastructure operator WaterBridge (WBI) has a real business in a strong basin, but investors are paying as if the growth is already guaranteed. The latest quarter only matched expectations, while the stock still trades at an extreme earnings multiple and projected cash burn exceeds available cash. For investors, the risk is paying up for future growth before the company has funded it.

WBI has a Zen Rating of D, a Sell recommendation. The Component Grades show where the problem sits: Value, Sentiment, and Financials all earn D grades, while nothing scores above C. That points to an expensive stock with weak financial support and limited investor conviction. Bottom line: the Permian opportunity is real, but WaterBridge looks priced for a level of execution the business has not yet delivered.

🔥 HOT: Pharma giant Merck (MRK) is giving investors a lot more than just Keytruda, its blockbuster cancer immunotherapy. Third-quarter results were strong enough for management to raise its 2026 outlook; sales of aforementioned Keytruda as well as Gardasil are growing, and the pipeline keeps producing fresh catalysts across MASH, COPD, and HIV. For investors, that matters because Merck is proving it has multiple ways to grow even as the market worries about future patent pressure.

Our quant ratings have taken note of the strong trajectory. MRK has a Zen Rating of A, a Strong Buy recommendation. This is truly an elite rating, with stocks earning this rating historically outperforming the S&P by nearly 3 to 1. The underlying Component Grades show why the setup looks so balanced: Momentum and Safety both earn A grades, while Value, Sentiment, Financials, and Artificial Intelligence receive B grades. That means the stock trend is strong, the business remains relatively stable, and analyst confidence is moving in the right direction. Bottom line: Merck has a raised outlook, several pipeline catalysts, and broad support behind the move.

Note: Looking for more up-and-coming stocks? Get our top picks for November here.

🥶 NOT: Las Vegas venue operator Sphere Entertainment (SPHR) is running into the problem every hit-driven business eventually faces: what comes next? Demand for its Wizard of Oz production appears to be cooling, the latest quarter brought another loss, and analysts expect little revenue growth with losses continuing for years. For investors, that means the Sphere still needs a second major success before the economics look convincing.

The quant ratings reflect these headwinds. SPHR has a Zen Rating of D, a Sell recommendation. The Component Grades reinforce that concern: Sentiment earns an F, while Value and Artificial Intelligence receive D grades. That tells us expectations are fading, the valuation remains hard to justify, and the market wants proof before rewarding the next chapter. Bottom line: the venue itself is impressive, but one fading hit is not enough to support the story.

What to Do Next?

• 77 Best Stocks NOW! >
• Options Trading with the Zen Ratings >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.